FALSEJun 30, 20242024Q2000159859912-31iso4217:EURxbrli:sharesiso4217:EURxbrli:sharesinpha:subsidiaryinpha:employeeinpha:sharexbrli:pureutr:Rateinpha:loan_agreementiso4217:USDinpha:loaninpha:target_optioninpha:optioninpha:preclinicalMoleculeinpha:licensing_agreement00015985992024-01-012024-06-3000015985992024-06-3000015985992023-12-3100015985992023-01-012023-06-3000015985992022-12-3100015985992023-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2022-12-310001598599ifrs-full:PreferenceSharesMemberifrs-full:IssuedCapitalMember2022-12-310001598599ifrs-full:IssuedCapitalMember2022-12-310001598599ifrs-full:SharePremiumMember2022-12-310001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2022-12-310001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-12-310001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2022-12-310001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2023-01-012023-06-300001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2023-01-012023-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2023-01-012023-06-300001598599ifrs-full:IssuedCapitalMember2023-01-012023-06-300001598599ifrs-full:SharePremiumMember2023-01-012023-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2023-06-300001598599ifrs-full:PreferenceSharesMemberifrs-full:IssuedCapitalMember2023-06-300001598599ifrs-full:IssuedCapitalMember2023-06-300001598599ifrs-full:SharePremiumMember2023-06-300001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2023-06-300001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-06-300001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2023-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2023-12-310001598599ifrs-full:PreferenceSharesMemberifrs-full:IssuedCapitalMember2023-12-310001598599ifrs-full:IssuedCapitalMember2023-12-310001598599ifrs-full:SharePremiumMember2023-12-310001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2023-12-310001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-12-310001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2023-12-310001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2024-01-012024-06-300001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-06-300001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2024-01-012024-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2024-01-012024-06-300001598599ifrs-full:IssuedCapitalMember2024-01-012024-06-300001598599ifrs-full:SharePremiumMember2024-01-012024-06-300001598599ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2024-06-300001598599ifrs-full:PreferenceSharesMemberifrs-full:IssuedCapitalMember2024-06-300001598599ifrs-full:IssuedCapitalMember2024-06-300001598599ifrs-full:SharePremiumMember2024-06-300001598599ifrs-full:RetainedEarningsExcludingProfitLossForReportingPeriodMember2024-06-300001598599ifrs-full:AccumulatedOtherComprehensiveIncomeMember2024-06-300001598599ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember2024-06-300001598599inpha:AgreementRelatedToIPH6101WithSanofiMember2024-01-012024-06-3000015985992024-06-102024-06-100001598599inpha:IssuedCapitalFreeOfSubscriptionMember2024-06-102024-06-100001598599inpha:ExerciseOfShareWarrantsMemberifrs-full:OrdinarySharesMember2024-06-102024-06-100001598599inpha:DefinitiveAcquisitionOfFreeSharesMember2024-06-100001598599ifrs-full:OrdinarySharesMember2024-06-102024-06-100001598599ifrs-full:OrdinarySharesMember2024-06-100001598599inpha:FreeSharesMember2024-06-100001598599inpha:FreeSharesMemberifrs-full:SharePremiumMember2024-06-102024-06-1000015985992023-01-012023-12-310001598599inpha:SICAVAndMutualFundsMembersrt:MinimumMember2024-06-300001598599inpha:SICAVAndMutualFundsMembersrt:MaximumMember2024-06-300001598599inpha:CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember2024-06-300001598599inpha:CashCashEquivalentsAndFinancialAssetsDenominatedInUSDollarsMember2023-12-3100015985992019-01-012019-12-3100015985992020-01-012020-12-310001598599ifrs-full:GuaranteesMember2024-06-300001598599ifrs-full:GuaranteesMember2023-12-310001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2024-06-300001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2024-01-012024-06-300001598599inpha:AgreementWithSanofiMember2023-12-310001598599ifrs-full:LicencesMember2022-12-310001598599ifrs-full:OtherIntangibleAssetsMember2022-12-310001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2022-12-310001598599ifrs-full:LicencesMember2023-01-012023-06-300001598599ifrs-full:OtherIntangibleAssetsMember2023-01-012023-06-300001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2023-01-012023-06-300001598599ifrs-full:LicencesMember2023-06-300001598599ifrs-full:OtherIntangibleAssetsMember2023-06-300001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2023-06-300001598599ifrs-full:LicencesMember2023-12-310001598599ifrs-full:OtherIntangibleAssetsMember2023-12-310001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2023-12-310001598599ifrs-full:LicencesMember2024-01-012024-06-300001598599ifrs-full:OtherIntangibleAssetsMember2024-01-012024-06-300001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2024-01-012024-06-300001598599ifrs-full:LicencesMember2024-06-300001598599ifrs-full:OtherIntangibleAssetsMember2024-06-300001598599ifrs-full:IntangibleAssetsUnderDevelopmentMember2024-06-300001598599inpha:MonalizumabAgreementMember2024-01-012024-06-300001598599inpha:AgreementWithOregaBiotechMember2023-01-012023-06-300001598599inpha:MonalizumabAgreementMember2023-01-012023-06-300001598599inpha:MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember2024-06-300001598599inpha:MonalizumabRightsUnderThe2014MonalizumabNKG2ANovoNordiskAgreementMember2023-12-310001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2019-06-012019-06-300001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2020-04-012020-04-300001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2020-06-012020-06-300001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2022-01-012022-01-310001598599inpha:AgreementRelatedToIPH5201WithAstraZenecaMember2022-06-012022-06-010001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2022-10-012022-10-310001598599inpha:IPH5201AntiCD39RightsAcquiredFromOregaBiotechMember2023-07-012023-07-310001598599inpha:IPH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember2017-07-310001598599inpha:IPH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember2020-10-012020-10-310001598599inpha:IPH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember2024-06-300001598599inpha:IPH5401AntiC5aRRightsAcquiredFromNovoNordiskASMember2022-07-012022-12-310001598599ifrs-full:LandAndBuildingsMember2022-12-310001598599inpha:LaboratoryEquipmentAndOtherMember2022-12-310001598599ifrs-full:ConstructionInProgressMember2022-12-310001598599ifrs-full:RightofuseAssetsMember2022-12-310001598599ifrs-full:LandAndBuildingsMember2023-01-012023-06-300001598599inpha:LaboratoryEquipmentAndOtherMember2023-01-012023-06-300001598599ifrs-full:ConstructionInProgressMember2023-01-012023-06-300001598599ifrs-full:RightofuseAssetsMember2023-01-012023-06-300001598599ifrs-full:LandAndBuildingsMember2023-06-300001598599inpha:LaboratoryEquipmentAndOtherMember2023-06-300001598599ifrs-full:ConstructionInProgressMember2023-06-300001598599ifrs-full:RightofuseAssetsMember2023-06-300001598599ifrs-full:LandAndBuildingsMember2023-12-310001598599inpha:LaboratoryEquipmentAndOtherMember2023-12-310001598599ifrs-full:ConstructionInProgressMember2023-12-310001598599ifrs-full:RightofuseAssetsMember2023-12-310001598599ifrs-full:LandAndBuildingsMember2024-01-012024-06-300001598599inpha:LaboratoryEquipmentAndOtherMember2024-01-012024-06-300001598599ifrs-full:ConstructionInProgressMember2024-01-012024-06-300001598599ifrs-full:RightofuseAssetsMember2024-01-012024-06-300001598599ifrs-full:LandAndBuildingsMember2024-06-300001598599inpha:LaboratoryEquipmentAndOtherMember2024-06-300001598599ifrs-full:ConstructionInProgressMember2024-06-300001598599ifrs-full:RightofuseAssetsMember2024-06-300001598599ifrs-full:RightofuseAssetsMember2023-03-152023-03-150001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2023-03-152023-03-1500015985992024-02-012024-02-290001598599srt:ScenarioForecastMember2024-07-012024-07-310001598599inpha:PGELoanAgreementSocieteGeneraleMember2023-12-310001598599inpha:PGELoanAgreementSocieteGeneraleMember2024-01-012024-06-300001598599inpha:PGELoanAgreementSocieteGeneraleMember2024-06-300001598599inpha:PGELoanAgreementBNPParibasMember2023-12-310001598599inpha:PGELoanAgreementBNPParibasMember2024-01-012024-06-300001598599inpha:PGELoanAgreementBNPParibasMember2024-06-300001598599inpha:PGELoanAgreementAccruedInterestMember2023-12-310001598599inpha:PGELoanAgreementAccruedInterestMember2024-01-012024-06-300001598599inpha:PGELoanAgreementAccruedInterestMember2024-06-300001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2023-12-310001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2024-01-012024-06-300001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2024-06-300001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2023-12-310001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2024-01-012024-06-300001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2024-06-300001598599inpha:LeaseFinancingObligationsEquipmentMember2023-12-310001598599inpha:LeaseFinancingObligationsEquipmentMember2024-01-012024-06-300001598599inpha:LeaseFinancingObligationsEquipmentMember2024-06-300001598599inpha:LeaseFinancingObligationsVehiclesMember2023-12-310001598599inpha:LeaseFinancingObligationsVehiclesMember2024-01-012024-06-300001598599inpha:LeaseFinancingObligationsVehiclesMember2024-06-300001598599inpha:LeaseFinancingObligationsPrintersMember2023-12-310001598599inpha:LeaseFinancingObligationsPrintersMember2024-01-012024-06-300001598599inpha:LeaseFinancingObligationsPrintersMember2024-06-300001598599inpha:LoanEquipmentMember2023-12-310001598599inpha:LoanEquipmentMember2024-01-012024-06-300001598599inpha:LoanEquipmentMember2024-06-300001598599inpha:LoanBuildingMember2023-12-310001598599inpha:LoanBuildingMember2024-01-012024-06-300001598599inpha:LoanBuildingMember2024-06-300001598599inpha:PGELoanAgreementSocieteGeneraleMember2022-12-310001598599inpha:PGELoanAgreementSocieteGeneraleMember2023-01-012023-06-300001598599inpha:PGELoanAgreementSocieteGeneraleMember2023-06-300001598599inpha:PGELoanAgreementBNPParibasMember2022-12-310001598599inpha:PGELoanAgreementBNPParibasMember2023-01-012023-06-300001598599inpha:PGELoanAgreementBNPParibasMember2023-06-300001598599inpha:PGELoanAgreementAccruedInterestMember2022-12-310001598599inpha:PGELoanAgreementAccruedInterestMember2023-01-012023-06-300001598599inpha:PGELoanAgreementAccruedInterestMember2023-06-300001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2022-12-310001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2023-01-012023-06-300001598599inpha:LeaseFinancingObligationsBuildingLeVirageMember2023-06-300001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2022-12-310001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2023-01-012023-06-300001598599inpha:LeaseFinancingObligationsInnateIncPremisesMember2023-06-300001598599inpha:LeaseFinancingObligationsEquipmentMember2022-12-310001598599inpha:LeaseFinancingObligationsEquipmentMember2023-01-012023-06-300001598599inpha:LeaseFinancingObligationsEquipmentMember2023-06-300001598599inpha:LeaseFinancingObligationsVehiclesMember2022-12-310001598599inpha:LeaseFinancingObligationsVehiclesMember2023-01-012023-06-300001598599inpha:LeaseFinancingObligationsVehiclesMember2023-06-300001598599inpha:LeaseFinancingObligationsPrintersMember2022-12-310001598599inpha:LeaseFinancingObligationsPrintersMember2023-01-012023-06-300001598599inpha:LeaseFinancingObligationsPrintersMember2023-06-300001598599inpha:LoanEquipmentMember2022-12-310001598599inpha:LoanEquipmentMember2023-01-012023-06-300001598599inpha:LoanEquipmentMember2023-06-300001598599inpha:LoanBuildingMember2022-12-310001598599inpha:LoanBuildingMember2023-01-012023-06-300001598599inpha:LoanBuildingMember2023-06-300001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2022-01-050001598599inpha:PGELoanAgreementSocieteGeneraleMember2022-01-050001598599inpha:PGELoanAgreementBNPParibasMember2022-01-050001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2022-01-052022-01-050001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2022-08-310001598599inpha:PGELoanAgreementSocieteGeneraleAndBNPParibasMember2022-08-312022-08-310001598599inpha:PGELoanAgreementSocieteGeneraleMember2022-08-310001598599inpha:PGELoanAgreementBNPParibasMember2022-08-310001598599inpha:PGELoanAgreementSocieteGeneraleMember2022-08-012022-08-310001598599inpha:PGELoanAgreementSocieteGeneraleMemberifrs-full:GuaranteesMember2022-08-310001598599inpha:PGELoanAgreementBNPParibasMemberifrs-full:GuaranteesMember2022-08-310001598599inpha:LoanAgreementWithSocitGnraleMember2017-07-030001598599inpha:LoanAgreementWithSocitGnraleMember2018-12-310001598599inpha:LoanAgreementWithSocitGnraleMember2019-12-310001598599inpha:LoanAgreementWithSocitGnraleMember2019-08-302019-08-300001598599inpha:LoanAgreementWithSocitGnraleMember2024-06-300001598599inpha:LoanAgreementWithSocitGnraleMember2017-07-032017-07-030001598599ifrs-full:OtherDisposalsOfAssetsMemberinpha:LoanAgreementWithSocitGnraleMember2024-07-012024-07-310001598599ifrs-full:FixedInterestRateMemberinpha:LoanAgreementWithSocitGnraleMember2024-06-300001598599ifrs-full:RightofuseAssetsMember2023-03-152023-03-150001598599ifrs-full:NotLaterThanOneYearMemberinpha:PGELoanAgreementSocieteGeneraleMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:PGELoanAgreementSocieteGeneraleMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:PGELoanAgreementSocieteGeneraleMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:PGELoanAgreementBNPParibasMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:PGELoanAgreementBNPParibasMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:PGELoanAgreementBNPParibasMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:PGELoanAgreementAccruedInterestMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:PGELoanAgreementAccruedInterestMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:PGELoanAgreementAccruedInterestMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LeaseFinancingObligationsBuildingLeVirageMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LeaseFinancingObligationsBuildingLeVirageMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LeaseFinancingObligationsBuildingLeVirageMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LeaseFinancingObligationsInnateIncPremisesMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LeaseFinancingObligationsInnateIncPremisesMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LeaseFinancingObligationsInnateIncPremisesMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LeaseFinancingObligationsEquipmentMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LeaseFinancingObligationsEquipmentMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LeaseFinancingObligationsEquipmentMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LeaseFinancingObligationsVehiclesMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LeaseFinancingObligationsVehiclesMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LeaseFinancingObligationsVehiclesMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LeaseFinancingObligationsPrintersMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LeaseFinancingObligationsPrintersMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LeaseFinancingObligationsPrintersMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LoanEquipmentMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LoanEquipmentMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LoanEquipmentMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMemberinpha:LoanBuildingMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMemberinpha:LoanBuildingMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMemberinpha:LoanBuildingMember2024-06-300001598599ifrs-full:NotLaterThanOneYearMember2024-06-300001598599ifrs-full:LaterThanTwoYearsAndNotLaterThanFiveYearsMember2024-06-300001598599ifrs-full:LaterThanFiveYearsMember2024-06-300001598599inpha:RetirementDefinedBenefitMember2024-06-300001598599inpha:RetirementDefinedBenefitMember2023-12-310001598599inpha:SeniorityAwardsMember2024-06-300001598599inpha:SeniorityAwardsMember2023-12-310001598599ifrs-full:OrdinarySharesMember2024-06-300001598599inpha:The2016FreePreferredSharesMember2024-06-300001598599inpha:The2017FreePreferredSharesMember2024-06-300001598599inpha:CompanySavingPlanMember2024-01-012024-06-300001598599inpha:CompanySavingPlanEmployerTopUpMember2024-01-012024-06-300001598599inpha:BSAAR2012Member2024-01-012024-06-300001598599inpha:BSAAR2012Member2024-06-300001598599inpha:BSAAR2011Member2024-06-302024-06-300001598599inpha:BSAAR2011Member2024-06-300001598599inpha:BSAAR2012Member2024-06-302024-06-300001598599inpha:BSAAR2015Member2024-06-302024-06-300001598599inpha:BSAAR2015Member2024-06-300001598599inpha:AGAPManagement20161Member2024-06-302024-06-300001598599inpha:AGAPManagement20161Member2024-06-300001598599inpha:AGAPEmployees20161Member2024-06-302024-06-300001598599inpha:AGAPEmployees20161Member2024-06-300001598599inpha:AGAManagement20161Member2024-06-302024-06-300001598599inpha:AGAManagement20161Member2024-06-300001598599inpha:AGAPManagement20162Member2024-06-302024-06-300001598599inpha:AGAPManagement20162Member2024-06-300001598599inpha:AGAManagement20162Member2024-06-302024-06-300001598599inpha:AGAManagement20162Member2024-06-300001598599inpha:AGAPEmployees20171Member2024-06-302024-06-300001598599inpha:AGAPEmployees20171Member2024-06-300001598599inpha:AGAPManagement20171Member2024-06-302024-06-300001598599inpha:AGAPManagement20171Member2024-06-300001598599inpha:AGAEmployees2017Member2024-06-302024-06-300001598599inpha:AGAEmployees2017Member2024-06-300001598599inpha:AGABonus20181Member2024-06-302024-06-300001598599inpha:AGABonus20181Member2024-06-300001598599inpha:AGAPPerfEmployees20181Member2024-06-302024-06-300001598599inpha:AGAPPerfEmployees20181Member2024-06-300001598599inpha:AGAPPerfManagement20181Member2024-06-302024-06-300001598599inpha:AGAPPerfManagement20181Member2024-06-300001598599inpha:AGAEmployees2018Member2024-06-302024-06-300001598599inpha:AGAEmployees2018Member2024-06-300001598599inpha:AGANewMembers20171Member2024-06-302024-06-300001598599inpha:AGANewMembers20171Member2024-06-300001598599inpha:AGABonus20191Member2024-06-302024-06-300001598599inpha:AGABonus20191Member2024-06-300001598599inpha:AGABonus202012Member2024-06-302024-06-300001598599inpha:AGABonus202012Member2024-06-300001598599inpha:AGAPEmployees20201Member2024-06-302024-06-300001598599inpha:AGAPEmployees20201Member2024-06-300001598599inpha:AGAPManagement20201Member2024-06-302024-06-300001598599inpha:AGAPManagement20201Member2024-06-300001598599inpha:AGABonus20211Member2024-06-302024-06-300001598599inpha:AGABonus20211Member2024-06-300001598599inpha:AGAPEmployees20211Member2024-06-302024-06-300001598599inpha:AGAPEmployees20211Member2024-06-300001598599inpha:AGAPManagement20211Member2024-06-302024-06-300001598599inpha:AGAPManagement20211Member2024-06-300001598599inpha:AGAPlanEpargneEntreprise2022Member2024-06-302024-06-300001598599inpha:AGAPlanEpargneEntreprise2022Member2024-06-300001598599inpha:AGABonus20221Member2024-06-302024-06-300001598599inpha:AGABonus20221Member2024-06-300001598599inpha:AGAPerfEmployees20221Member2024-06-302024-06-300001598599inpha:AGAPerfEmployees20221Member2024-06-300001598599inpha:AGAPerfManagement20221Member2024-06-302024-06-300001598599inpha:AGAPerfManagement20221Member2024-06-300001598599inpha:AGAPlanEpargneEntreprise2023Member2024-06-302024-06-300001598599inpha:AGAPlanEpargneEntreprise2023Member2024-06-300001598599inpha:AGANewMembers20231Member2024-06-302024-06-300001598599inpha:AGANewMembers20231Member2024-06-300001598599inpha:AGAPerfEmployees20231Member2024-06-302024-06-300001598599inpha:AGAPerfEmployees20231Member2024-06-300001598599inpha:AGAPerfManagement20231Member2024-06-302024-06-300001598599inpha:AGAPerfManagement20231Member2024-06-300001598599inpha:AGANewMembers20241Member2024-06-302024-06-300001598599inpha:AGANewMembers20241Member2024-06-300001598599inpha:AGAPlanEpargneEntreprise2024Member2024-06-302024-06-300001598599inpha:AGAPlanEpargneEntreprise2024Member2024-06-300001598599inpha:StockOptions20201Member2024-06-302024-06-300001598599inpha:StockOptions20201Member2024-06-300001598599inpha:AGAP2019Employees2019Member2024-06-302024-06-300001598599inpha:AGAP2019Employees2019Member2024-06-300001598599inpha:AGAP2019Management2019Member2024-06-302024-06-300001598599inpha:AGAP2019Management2019Member2024-06-300001598599inpha:BSA20112Member2024-06-302024-06-300001598599inpha:BSA20112Member2024-06-300001598599inpha:BSA2013Member2024-06-302024-06-300001598599inpha:BSA2013Member2024-06-300001598599inpha:BSA2014Member2024-06-302024-06-300001598599inpha:BSA2014Member2024-06-300001598599inpha:BSA20151Member2024-06-302024-06-300001598599inpha:BSA20151Member2024-06-300001598599inpha:BSA20152Member2024-06-302024-06-300001598599inpha:BSA20152Member2024-06-300001598599inpha:BSA2017Member2024-06-302024-06-300001598599inpha:BSA2017Member2024-06-300001598599inpha:BSA20221Member2024-06-302024-06-300001598599inpha:BSA20221Member2024-06-300001598599inpha:BSA20231Member2024-06-302024-06-300001598599inpha:BSA20231Member2024-06-300001598599ifrs-full:WarrantsMember2024-06-302024-06-300001598599ifrs-full:WarrantsMember2024-06-300001598599inpha:NonCurrentFinancialAssetsMember2024-06-300001598599inpha:NonCurrentFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599inpha:NonCurrentFinancialAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001598599inpha:TradeReceivablesAndOthersMember2024-06-300001598599inpha:TradeReceivablesAndOthersMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599inpha:TradeReceivablesAndOthersMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001598599inpha:FinancialAssetsShortTermInvestmentsMember2024-06-300001598599inpha:FinancialAssetsShortTermInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599inpha:FinancialAssetsShortTermInvestmentsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001598599inpha:FinancialAssetsCashAndCashEquivalentsMember2024-06-300001598599inpha:FinancialAssetsCashAndCashEquivalentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599inpha:FinancialAssetsCashAndCashEquivalentsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001598599ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2024-06-300001598599inpha:FinancialLiabilitiesNonCurrentPortionMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:FinancialLiabilitiesNonCurrentPortionMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:FinancialLiabilitiesNonCurrentPortionMember2024-06-300001598599inpha:FinancialLiabilitiesCurrentPortionMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:FinancialLiabilitiesCurrentPortionMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:FinancialLiabilitiesCurrentPortionMember2024-06-300001598599inpha:TradePayablesAndOthersMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:TradePayablesAndOthersMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:TradePayablesAndOthersMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2024-06-300001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2024-06-300001598599inpha:NonCurrentFinancialAssetsMember2023-12-310001598599inpha:NonCurrentFinancialAssetsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599inpha:NonCurrentFinancialAssetsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001598599inpha:TradeReceivablesAndOthersMember2023-12-310001598599inpha:TradeReceivablesAndOthersMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599inpha:TradeReceivablesAndOthersMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001598599inpha:FinancialAssetsShortTermInvestmentsMember2023-12-310001598599inpha:FinancialAssetsShortTermInvestmentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599inpha:FinancialAssetsShortTermInvestmentsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001598599inpha:FinancialAssetsCashAndCashEquivalentsMember2023-12-310001598599inpha:FinancialAssetsCashAndCashEquivalentsMemberifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599inpha:FinancialAssetsCashAndCashEquivalentsMemberifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001598599ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember2023-12-310001598599inpha:FinancialLiabilitiesNonCurrentPortionMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:FinancialLiabilitiesNonCurrentPortionMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:FinancialLiabilitiesNonCurrentPortionMember2023-12-310001598599inpha:FinancialLiabilitiesCurrentPortionMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:FinancialLiabilitiesCurrentPortionMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:FinancialLiabilitiesCurrentPortionMember2023-12-310001598599inpha:TradePayablesAndOthersMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMemberinpha:TradePayablesAndOthersMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMemberinpha:TradePayablesAndOthersMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember2023-12-310001598599ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember2023-12-310001598599inpha:CollaborationAndLicensingAgreementsMember2024-01-012024-06-300001598599inpha:CollaborationAndLicensingAgreementsMember2023-01-012023-06-300001598599inpha:AgreementRelatedToIPH6101WithSanofiMember2023-01-012023-06-300001598599inpha:AgreementWithSanofi2022ANKETIPH62Member2024-01-012024-06-300001598599inpha:AgreementWithSanofi2022ANKETIPH62Member2023-01-012023-06-300001598599inpha:AgreementWithSanofi2022ANKETIPH67Member2024-01-012024-06-300001598599inpha:AgreementWithSanofi2022ANKETIPH67Member2023-01-012023-06-300001598599inpha:AgreementWithTakedaMember2024-01-012024-06-300001598599inpha:AgreementWithTakedaMember2023-01-012023-06-300001598599inpha:IPH5201AndAdvoralimabAgreementsMember2024-01-012024-06-300001598599inpha:IPH5201AndAdvoralimabAgreementsMember2023-01-012023-06-300001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2022-12-310001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-01-012023-06-300001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-06-300001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-12-310001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2024-01-012024-06-300001598599inpha:DeferredRevenueMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2024-06-300001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2022-12-310001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-01-012023-06-300001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-06-300001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2023-12-310001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2024-01-012024-06-300001598599inpha:CollaborationLiabilitiesMemberinpha:A2015AstraZenecaMonalizumabAgreementsMember2024-06-300001598599inpha:A2018AstraZenecaIPH5201AgreementMember2024-01-012024-06-300001598599inpha:A2018AstraZenecaIPH5201AgreementMember2023-01-012023-06-300001598599inpha:SanofiResearchCollaborationAndLicensingAgreementMember2023-03-012023-03-310001598599inpha:SanofiResearchCollaborationAndLicensingAgreementMember2023-03-310001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2023-12-190001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2023-12-192023-12-190001598599inpha:AgreementsWithGenzymeForNKCellEngagesMember2023-03-012023-03-310001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2023-03-012023-03-310001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2023-01-252023-01-250001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2022-12-310001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2023-01-012023-06-300001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2023-06-300001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2023-12-310001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2024-01-012024-06-300001598599inpha:DeferredRevenueMemberinpha:SanofiResearchCollaborationAndLicensingAgreementMember2024-06-300001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2024-01-012024-06-300001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2023-03-310001598599inpha:AgreementsWithSanofiForNKCellEngagesMember2024-06-300001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2023-12-310001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2024-01-012024-06-300001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2024-06-300001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2023-12-310001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2024-01-012024-06-300001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2024-06-300001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2023-12-310001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2024-01-012024-06-300001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2024-06-300001598599inpha:DeferredRevenueMember2023-12-310001598599inpha:DeferredRevenueMember2024-01-012024-06-300001598599inpha:DeferredRevenueMember2024-06-300001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2022-12-310001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2023-01-012023-06-300001598599inpha:MonalizumabMemberinpha:DeferredRevenueMember2023-06-300001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2022-12-310001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2023-01-012023-06-300001598599inpha:SanofiOptionsMemberinpha:DeferredRevenueMember2023-06-300001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2022-12-310001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2023-01-012023-06-300001598599inpha:SanofiServicesMemberinpha:DeferredRevenueMember2023-06-300001598599inpha:DeferredRevenueMember2022-12-310001598599inpha:DeferredRevenueMember2023-01-012023-06-300001598599inpha:DeferredRevenueMember2023-06-300001598599inpha:ResearchAndDevelopmentMember2024-01-012024-06-300001598599ifrs-full:SellingGeneralAndAdministrativeExpenseMember2024-01-012024-06-300001598599inpha:ResearchAndDevelopmentMember2023-01-012023-06-300001598599ifrs-full:SellingGeneralAndAdministrativeExpenseMember2023-01-012023-06-300001598599inpha:ResearchAndDevelopmentMember2024-06-300001598599inpha:ResearchAndDevelopmentMember2023-06-300001598599inpha:AdministrationMember2024-06-300001598599inpha:AdministrationMember2023-06-300001598599srt:ScenarioForecastMember2024-07-012024-12-310001598599inpha:PreclinicalServicesMember2024-06-300001598599inpha:ClinicalServicesMember2024-06-300001598599inpha:ChangesToCommitmentsMemberinpha:LoanAgreementWithSocitGnraleMember2024-07-012024-07-310001598599inpha:GrantsOfEmployeeEquityInstrumentsMember2024-06-300001598599ifrs-full:TaxContingentLiabilityMember2023-12-310001598599inpha:NovoNordiskASMember2024-06-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
Date of report: September 12, 2024
Commission File Number: 001-39084
Innate Pharma SA
(Translation of registrant's name into English)
Innate Pharma SA
117 Avenue de Luminy—BP 30191
13009 Marseille, France
+ 33 (0) 4 30 30 30
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ] Form 40-F [ ]
INCORPORATION BY REFERENCE
This Report on Form 6-K and Exhibit 99.2 to this Report on Form 6-K (excluding the Statutory Auditors' Review Report on the Half-Yearly Financial Information on page 43 of Exhibit 99.2) shall be deemed to be incorporated by reference into the registration statement on Form F-3 (File No. 333-276164) and registration statement on Form S-8 (File No. 333-282031) of Innate Pharma S.A. (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
Exhibit
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
INNATE PHARMA S.A.
Date: September 12, 2024 By: /s/ Hervé Brailly Name: Hervé Brailly
Title: Interim Chief Executive Officer
